In two extensive studies conducted prospectively within cancer genetics services, it was determined that by the age of 70, individuals carrying BRCA1 pathogenic variants faced a breast cancer risk ranging from 60% to 66%, while those with BRCA2 pathogenic variants exhibited a risk between 55% and 61%. The gene discussed is BRCA2; the disease is breast cancer.